Superior prevention of calcium ionophore cataract by E64d.

[1]  L. David,et al.  Amelioration of cataracts and proteolysis in cultured lenses by cysteine protease inhibitor E64. , 1991, Investigative ophthalmology & visual science.

[2]  T. Shearer,et al.  Calpain II in two in vivo models of sugar cataract. , 1990, Experimental eye research.

[3]  K. Wang.  Developing selective inhibitors of calpain. , 1990, Trends in pharmacological sciences.

[4]  H. Kawasaki,et al.  Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function , 1987, FEBS letters.

[5]  R. Mellgren,et al.  Calcium‐dependent proteases: an enzyme system active at cellular membranes? , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  H. Kawasaki,et al.  The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol. , 1986, Journal of biochemistry.

[7]  T. Shearer,et al.  Purification of calpain II from rat lens and determination of endogenous substrates. , 1986, Experimental eye research.

[8]  B. Horecker,et al.  Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. , 1985, Biochemical and biophysical research communications.

[9]  K. Suzuki.  Reaction of calcium-activated neutral protease (CANP) with an epoxysuccinyl derivative (E64c) and iodoacetic acid. , 1983, Journal of biochemistry.

[10]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[11]  T. Shearer,et al.  Cysteine protease inhibitor E64 reduces the rate of formation of selenite cataract in the whole animal. , 1991, Current eye research.

[12]  T. Shearer,et al.  Selenite cataract: a review. , 1987, Current eye research.